Drug
Oxcarbazepine clinical trials
Also written Trileptal, Oxtellar XR and SPN-804O.
How studies write it
Studies that test it under each name
Brand
Other names
Combined with it in one product
Studies by the year they started
44 studies that test it; most in 2009 (5)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 3 |
| 2003 | 3 |
| 2004 | 4 |
| 2005 | 4 |
| 2006 | 4 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 24 · Other 20
Roxane Laboratories (5) · Novartis (4) · Bial - Portela C S.A. (3) · Supernus Pharmaceuticals, Inc. (3) · Novartis Pharmaceuticals (3) · Teva Pharmaceuticals USA (2) · All India Institute of Medical Sciences, Bhubaneswar (2) · Ranbaxy Laboratories Limited (2)
Often tested with
Tested in the same studies.
Carbamazepine (5) · Levetiracetam (4) · Valproic Acid (4) · Lamotrigine (4) · Topiramate (3) · Gabapentin (3) · Eslicarbazepine (3) · Eslicarbazepine (3)
Studies
Open first, then newest update. How each study uses Oxcarbazepine is read from its arms, and is right about nine times in ten.
Testing it · 44
- Gabapentin and Oxcarbazepine for Chronic Neuropathic Pain in Children and Adolescents: A Clinical Effectiveness StudyWithdrawnPhase 3Boston Children's HospitalNCT02219373Written as Oxcarbazepine
- Comparison b/w Carbamazepine vs Oxcarbazepine in Treatment of Trigeminal NeuralgiaActive, not recruitingNot applicableAbbasi Shaheed HospitalNCT07252453Written as oxcarbazepine
- Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)CompletedPhase 4Mario Negri Institute for Pharmacological ResearchNCT03689114Written as Low dose oxcarbazepine
- Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy VolunteersCompletedPhase 1Bial - Portela C S.A.NCT01679002Written as Oxcarbazepine
- Comparison of Oxcarbazepine Versus Carbamazepine in the Management of Trigeminal NeuralgiaActive, not recruitingPhase 4Jinnah Postgraduate Medical CentreNCT06849219Written as Oxcarbazepine
- Oxcarbazepine 600 mg Tablets Under Fasting ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00850174Written as Oxcarbazepine
- Oxcarbazepine 600 mg Tablets Under Non-Fasting ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00849797Written as Oxcarbazepine
- The Efficacy and Safety of Oral Oxcarbazepine 300-1200 mg/Day as Adjuvant Therapy in the Treatment of Bipolar Disorder I or II This Study is Not Being Conducted in the United States.CompletedPhase 4NovartisNCT00154323Written as Oxcarbazepine
- Comparision Efficacy of Carbamazepine & Oxcarbazepine in the Treatment of Trigeminal Neuralgia- a Randomised Clinical TrialStatus unknownPhase 4Postgraduate Institute of Dental Sciences RohtakNCT04996199Written as Oxcarbazepine
- Oxcarbazepine Versus Placebo in Childhood AutismCompletedNot applicableUniversity of Medicine and Dentistry of New JerseyNCT00467753Written as Oxcarbazepine
- A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on PadsevonilCompletedPhase 1UCB Biopharma S.P.R.L.NCT03695094Written as Oxcarbazepine
- Characterization of Epilepsy Patients BEEP 2bCompletedPhase 1Food and Drug Administration (FDA)NCT02707965Written as Oxcarbazepine (brand name vs generic drugs)
- Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset SeizuresCompletedPhase 2/3NobelpharmaNCT01051193Written as Oxcarbazepine
- Oxtellar Extended Release (Oxcarbazepine Extended Release) Patients With Trigeminal NeuralgiaWithdrawnPhase 4University of Colorado, DenverNCT03374709Written as Oxtellar XR 150Mg Extended Release Tablet
- Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar DisorderCompletedPhase 4All India Institute of Medical Sciences, BhubaneswarNCT02456896Written as Oxcarbazepine
- Protective Role of Oxcarbazepine in Multiple SclerosisCompletedPhase 2Queen Mary University of LondonNCT02104661Written as Oxcarbazepine
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedPhase 3Hannover Medical SchoolNCT02374567Written as Oxcarbazepine
- Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed ConditionsCompletedPhase 1Roxane LaboratoriesNCT01703468Written as Oxcarbazepine
- Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed ConditionsCompletedNot applicableRoxane LaboratoriesNCT00616863Written as Oxcarbazepine
- Bioequivalency Study of 600 mg Oxcarbazepine Tablets Under Fasting ConditionsCompletedNot applicableRoxane LaboratoriesNCT00616681Written as Oxcarbazepine
See all 44 studies that test Oxcarbazepine →
As the comparator · 2 — what is tested is compared with Oxcarbazepine
- The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy ChildrenStatus unknownPhase 4Dr Cipto Mangunkusumo General HospitalNCT05697614Written as Oxcarbazepine
- Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial EpilepsyCompletedPhase 4Korea UCB Co., Ltd.NCT01498822Written as Oxcarbazepine
Codes
What other systems call Oxcarbazepine · ClinicalTrials.gg INT006829
- MeSH (NLM) D000078330OxcarbazepineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) VZI5B1W380OXCARBAZEPINEConfirmed FDA, NLM, Wikidata
- RxNorm 32624Confirmed FDA, Wikidata
- Wikidata Q176301oxcarbazepineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47643OxcarbazepineOne source FDA
- DrugBank DB00776One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000078330 | Oxcarbazepine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | VZI5B1W380 | OXCARBAZEPINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 32624 | — | Confirmed FDA, Wikidata |
| Wikidata | Q176301 | oxcarbazepine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47643 | Oxcarbazepine | One source FDA |
| DrugBank | DB00776 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.